BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 10780759)

  • 1. Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
    Brightling CE; Ward R; Wardlaw AJ; Pavord ID
    Eur Respir J; 2000 Apr; 15(4):682-6. PubMed ID: 10780759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic bronchitis is an important cause of chronic cough.
    Brightling CE; Ward R; Goh KL; Wardlaw AJ; Pavord ID
    Am J Respir Crit Care Med; 1999 Aug; 160(2):406-10. PubMed ID: 10430705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of eosinophilic bronchitis.
    Joo JH; Park SJ; Park SW; Lee JH; Kim DJ; Uh ST; Kim YH; Park CS
    Korean J Intern Med; 2002 Mar; 17(1):31-7. PubMed ID: 12014210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational study of the natural history of eosinophilic bronchitis.
    Berry MA; Hargadon B; McKenna S; Shaw D; Green RH; Brightling CE; Wardlaw AJ; Pavord ID
    Clin Exp Allergy; 2005 May; 35(5):598-601. PubMed ID: 15898981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic bronchitis: clinical features, management and pathogenesis.
    Birring SS; Berry M; Brightling CE; Pavord ID
    Am J Respir Med; 2003; 2(2):169-73. PubMed ID: 14720015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
    Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
    Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophilic bronchitis without asthma--an additional rare cause for chronic persistent cough (CPC)? A 30-year old patient with severe CPC due to eosinophilic bronchitis without asthma or hyperreactivity].
    Kardos P
    Pneumologie; 2001 May; 55(5):249-52. PubMed ID: 11449611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study.
    Park SW; Lee YM; Jang AS; Lee JH; Hwangbo Y; Kim DJ; Park CS
    Chest; 2004 Jun; 125(6):1998-2004. PubMed ID: 15189914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case for serial examination of sputum inflammatory cells.
    Wong AG; Pavord ID; Sears MR; Hargreave FE
    Eur Respir J; 1996 Oct; 9(10):2174-5. PubMed ID: 8902485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and clinical features of nonasthmatic eosinophilic bronchitis].
    Dor-Wojnarowska A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):389-93. PubMed ID: 18080990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
    Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection.
    Lai K; Lin L; Liu B; Chen R; Tang Y; Luo W; Chen Q
    Respirology; 2016 May; 21(4):683-8. PubMed ID: 26969485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
    Brightling CE; Woltmann G; Wardlaw AJ; Pavord ID
    Eur Respir J; 1999 Nov; 14(5):1228-30. PubMed ID: 10596716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper-airway cough syndrome with latent eosinophilic bronchitis.
    Yu L; Wei W; Wang L; Huang Y; Shi C; Lü H; Qiu Z
    Lung; 2010; 188(1):71-6. PubMed ID: 19862573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
    Green RH; Brightling CE; Woltmann G; Parker D; Wardlaw AJ; Pavord ID
    Thorax; 2002 Oct; 57(10):875-9. PubMed ID: 12324674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to bronchodilator and clinical, pathophysiological features in patients with nonasthmatic eosinophilic bronchitis.
    Lai K; Yi F; Han L; Liu B; Zhang X; Xue Y; Luo W; Chen Q
    Clin Respir J; 2020 Mar; 14(3):242-249. PubMed ID: 31808598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic bronchitis: an important cause of prolonged cough.
    Brightling CE; Pavord ID
    Ann Med; 2000 Oct; 32(7):446-51. PubMed ID: 11087164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
    Brightling CE; Ward R; Woltmann G; Bradding P; Sheller JR; Dworski R; Pavord ID
    Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):878-82. PubMed ID: 10988099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: a pilot study.
    Cai C; He MZ; Zhong SQ; Tang Y; Sun BQ; Chen QL; Zhong NS
    Respir Med; 2012 Oct; 106(10):1369-75. PubMed ID: 22819521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of treatment with inhaled corticosteroids in nonasthmatic eosinophilic bronchitis: a randomized open label trial.
    Zhan W; Tang J; Chen X; Yi F; Han L; Liu B; Luo W; Chen Q; Lai K
    Ther Adv Respir Dis; 2019; 13():1753466619891520. PubMed ID: 31847717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.